What are the major opportunities in the NGS Oncology market? What are the strategies for the NGS Oncology market?

For detailed insights on the major opportunities and strategies in the NGS Oncology market, Read More

How does the NGS Oncology market relate to the overall economy and other similar markets?

For detailed insights on NGS Oncology's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the NGS Oncology market growth? SWOT analysis of the NGS Oncology market.

For detailed insights on the key dynamics influencing the NGS Oncology market growth and SWOT analysis of the NGS Oncology industry, Read More

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

NGS Oncology Global Market Report 2025

Name: NGS Oncology Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Sequencing Technology (Targeted Sequencing, Genomics, Transcriptomics, Epigenomics), By Offering (Platform, Kits, Services), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications), By End User (Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

NGS Oncology Market Overview

• NGS Oncology market size has reached to $17.36 billion in 2024

• Expected to grow to $29.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%

• Growth Driver: Increasing Cancer Prevalence Fueling The Growth Of The Market Due To Rising Demand For Precision Diagnostics

• Market Trend: Next-Generation Sequencing Technologies Transforming Oncology Research

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under NGS Oncology Market?

Next-generation sequencing (NGS) oncology refers to the use of advanced sequencing technologies to analyze the genetic makeup of cancer cells. It allows for the identification of specific mutations, genetic alterations, and biomarkers that can help guide personalized treatment plans, predict treatment responses, and improve the overall management of cancer patients. NGS oncology enables precision medicine, where therapies are tailored based on the genetic profile of the tumor.

The main sequencing technologies in NGS oncology include targeted sequencing, genomics, transcriptomics, and epigenomics. Targeted sequencing is a genomic technique that focuses on sequencing specific genes or regions of interest within the genome to identify genetic variations relevant to diseases or traits. These technologies are offered in the form of platforms, kits, and services. The workflow involves stages such as pre-sequencing, sequencing, and data analysis. They are used for various applications, including genetic screening, hereditary genetic testing, hematological malignancies, solid tumors, and others, catering to end users including hospitals and clinics, clinical research organizations (CROs), academic and research institutes, pharmaceutical and biotechnology companies, and others.

NGS Oncology Market Size and growth rate 2025 to 2029: Graph

What Is The NGS Oncology Market Size 2025 And Growth Rate?

The NGS oncology market size has grown rapidly in recent years. It will grow from $17.36 billion in 2024 to $19.33 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising cancer incidence, growing research in cancer genomics, increasing public awareness, expansion of healthcare infrastructure, and rising demand for personalized medicine.

What Is The NGS Oncology Market Growth Forecast?

The NGS oncology market size is expected to see rapid growth in the next few years. It will grow to $29.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the growth of companion diagnostics, the rising prevalence of cancer, the increase in government and healthcare investments, the expansion of clinical applications, and the rising popularity of targeted therapies. Major trends in the forecast period include the integration of AI and machine learning, advancements in single-cell sequencing, enhanced sequencing platforms, advancements in liquid biopsy technology, and advancements in high-throughput sequencing platforms.

The forecast of 11.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of tumor mutational profiling by inflating prices of Next Generation Sequencing panels and hybridization capture kits developed in South Korea and Belgium, resulting in delayed personalized therapy decisions and higher cancer care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The NGS Oncology Market Segmented?

1) By Sequencing Technology: Targeted Sequencing, Genomics, Transcriptomics, Epigenomics

2) By Offering: Platform, Kits, Services

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

4) By Application: Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications

5) By End User: Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Targeted Sequencing: Whole Exome Sequencing (WES), Amplicon-Based Sequencing, Hybridization-Based Sequencing

2) By Genomics: Whole Genome Sequencing (WGS), Structural Variant Detection, Copy Number Variation (CNV) Analysis

3) By Transcriptomics: RNA Sequencing, Single-Cell Transcriptomics, Non-coding RNA Analysis

4) By Epigenomics: DNA Methylation Sequencing, Chromatin Immunoprecipitation Sequencing, Histone Modification Analysis

What Is Driving The NGS Oncology Market? Increasing Cancer Prevalence Fueling The Growth Of The Market Due To Rising Demand For Precision Diagnostics

Increasing cancer prevalence is expected to propel the growth of the NGS oncology market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can spread to other parts of the body, disrupting normal bodily functions. Rising cancer prevalence is largely due to aging populations, as the risk of developing cancer increases with age. NGS oncology helps address rising cancer prevalence by enabling early detection, precise diagnosis, and personalized treatment through detailed genetic profiling of tumors. For instance, according to the American Cancer Society, a U.S.-based nonprofit organization, in 2022, around 20 million new cancer cases were reported globally, resulting in 9.7 million deaths; driven primarily by population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, increasing cancer prevalence will drive the growth of the NGS oncology industry.

Who Are The Major Players In The Global NGS Oncology Market?

Major companies operating in the NGS oncology market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.

What Are The Key Trends Of The Global NGS Oncology Market? Next-Generation Sequencing Technologies Transforming Oncology Research

Major companies operating in the NGS oncology market are focusing on developing innovative solutions such as liquid biopsy research assays to enable non-invasive, real-time cancer detection and monitoring through the analysis of circulating tumor DNA. A liquid biopsy research assay is a diagnostic test that analyzes biological fluids, such as blood, to detect genetic mutations or other molecular markers associated with cancer, allowing for non-invasive cancer detection and monitoring. For instance, in August 2024, Illumina Inc., a US-based biotechnology company specializing in next-generation sequencing (NGS) technology, expanded its oncology portfolio for NovaSeq X Series users. The company now offers the newly validated high-throughput TruSight Oncology 500 (TSO 500 HT) and the updated TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) liquid biopsy research assay. These enhanced assays enable laboratories to broaden oncology research capabilities for both tissue and liquid biopsy samples, featuring improved sequencing efficiency, reduced run times, and the ability to process larger sample volumes on the NovaSeq X Series for the first time.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The NGS Oncology Market? Deerfield Management Acquires Singular Genomics To Strengthen Research Capabilities

In December 2024, Deerfield Management Company, a US-based investment firm, acquired Singular Genomics for an undisclosed amount. With this acquisition, Deerfield Management Company aims to enhance its portfolio by integrating Singular Genomics' next-generation sequencing and spatial multiomics technologies, advancing research and clinical applications. Singular Genomics is a US-based biotechnology company specializing in next-generation sequencing and multiomics technologies.

What Is The Regional Outlook For The Global NGS Oncology Market?

North America was the largest region in the NGS oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the NGS Oncology Market?

The NGS oncology market consists of revenues earned by entities by providing services such as companion diagnostics, liquid biopsy analysis, genetic mutation analysis, bioinformatics, and data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The NGS oncology market also includes sales of target enrichment kits, library preparation kits, data analysis pipelines, bioinformatics software, and tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the NGS Oncology Industry?

The ngs oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ngs oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

NGS Oncology Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$19.33 billion
Revenue Forecast In 2034	$29.64 billion
Growth Rate	CAGR of 11.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The NGS oncology market covered in this report is segmented – 1) By Sequencing Technology: Targeted Sequencing, Genomics, Transcriptomics, Epigenomics 2) By Offering: Platform, Kits, Services 3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis 4) By Application: Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications 5) By End User: Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Targeted Sequencing: Whole Exome Sequencing (WES), Amplicon-Based Sequencing, Hybridization-Based Sequencing 2) By Genomics: Whole Genome Sequencing (WGS), Structural Variant Detection, Copy Number Variation (CNV) Analysis 3) By Transcriptomics: RNA Sequencing, Single-Cell Transcriptomics, Non-coding RNA Analysis 4) By Epigenomics: DNA Methylation Sequencing, Chromatin Immunoprecipitation Sequencing, Histone Modification Analysis
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. NGS Oncology Market Characteristics

3. NGS Oncology Market Trends And Strategies

4. NGS Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global NGS Oncology Growth Analysis And Strategic Analysis Framework

5.1. Global NGS Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global NGS Oncology Market Growth Rate Analysis

5.4. Global NGS Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global NGS Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global NGS Oncology Total Addressable Market (TAM)

6. NGS Oncology Market Segmentation

6.1. Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Sequencing

Genomics

Transcriptomics

Epigenomics

6.2. Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Platform

Kits

Services

6.3. Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pre-Sequencing

Sequencing

Data Analysis

6.4. Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Screening

Hereditary Genetic Testing

Hematological Malignancies

Solid Tumors

Other Applications

6.5. Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Clinical Research Organizations (CROs)

Academic And Research Institutes

Pharmaceutical And Biotechnology Companies

Other End Users

6.6. Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Exome Sequencing (WES)

Amplicon-Based Sequencing

Hybridization-Based Sequencing

6.7. Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing (WGS)

Structural Variant Detection

Copy Number Variation (CNV) Analysis

6.8. Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

RNA Sequencing

Single-Cell Transcriptomics

Non-coding RNA Analysis

6.9. Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Methylation Sequencing

Chromatin Immunoprecipitation Sequencing

Histone Modification Analysis

7. NGS Oncology Market Regional And Country Analysis

7.1. Global NGS Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global NGS Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS Oncology Market

8.1. Asia-Pacific NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS Oncology Market

9.1. China NGS Oncology Market Overview

9.2. China NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS Oncology Market

10.1. India NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS Oncology Market

11.1. Japan NGS Oncology Market Overview

11.2. Japan NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS Oncology Market

12.1. Australia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS Oncology Market

13.1. Indonesia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS Oncology Market

14.1. South Korea NGS Oncology Market Overview

14.2. South Korea NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS Oncology Market

15.1. Western Europe NGS Oncology Market Overview

15.2. Western Europe NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS Oncology Market

16.1. UK NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS Oncology Market

17.1. Germany NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS Oncology Market

18.1. France NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS Oncology Market

19.1. Italy NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS Oncology Market

20.1. Spain NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS Oncology Market

21.1. Eastern Europe NGS Oncology Market Overview

21.2. Eastern Europe NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS Oncology Market

22.1. Russia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS Oncology Market

23.1. North America NGS Oncology Market Overview

23.2. North America NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS Oncology Market

24.1. USA NGS Oncology Market Overview

24.2. USA NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS Oncology Market

25.1. Canada NGS Oncology Market Overview

25.2. Canada NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS Oncology Market

26.1. South America NGS Oncology Market Overview

26.2. South America NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS Oncology Market

27.1. Brazil NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS Oncology Market

28.1. Middle East NGS Oncology Market Overview

28.2. Middle East NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS Oncology Market

29.1. Africa NGS Oncology Market Overview

29.2. Africa NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS Oncology Market Competitive Landscape And Company Profiles

30.1. NGS Oncology Market Competitive Landscape

30.2. NGS Oncology Market Company Profiles

30.2.1. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. NGS Oncology Market Other Major And Innovative Companies

31.1. Qiagen N.V.

31.2. Tecan Trading AG

31.3. Myriad Genetics

31.4. Takara Bio Inc.

31.5. Beijing Genomics Institute (BGI)

31.6. Caris Life Sciences

31.7. Foundation Medicine

31.8. Paradigm Diagnostics

31.9. Pacific Bioscience

31.10. Horizon Discovery Group plc

31.11. Creative-Biolabs

31.12. Xcelris Labs Ltd.

31.13. Partek Inc.

31.14. 4baseCare

31.15. SciGenom Labs Pvt. Ltd.

32. Global NGS Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS Oncology Market

34. Recent Developments In The NGS Oncology Market

35. NGS Oncology Market High Potential Countries, Segments and Strategies

35.1 NGS Oncology Market In 2029 - Countries Offering Most New Opportunities

35.2 NGS Oncology Market In 2029 - Segments Offering Most New Opportunities

35.3 NGS Oncology Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global NGS Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global NGS Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Hoffmann-La Roche Ltd. Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Agilent Technologies Inc. Financial Performance

Table 83: Eurofins Scientific SE Financial Performance

Table 84: Illumina Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global NGS Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global NGS Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Hoffmann-La Roche Ltd. Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Agilent Technologies Inc. Financial Performance

Figure 83: Eurofins Scientific SE Financial Performance

Figure 84: Illumina Inc. Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Community Oncology Services Global Market Report 2025 – By Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), By Cancer Type (Breast Cancer, Lung Cancer, Kidney ...

Oncology Companion Diagnostics Global Market Report 2025 – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types), By ...

Oncology Information Systems Global Market Report 2025 – By Product (Solutions, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology), By End User (Hospitals And Diagnostic Imag...

Oncology Devices Global Market Report 2025 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hospitals, Can...

Oncologists Global Market Report 2025 – By Cancer Diagnostics and Treatment (Cancer Diagnostics, Cancer Treatment), By Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head and Ne...

Oncology Nutrition Global Market Report 2025 – By Cancer Type (Blood Cancer, Breast Cancer, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types ), By Nutrition (Enteral Nutrition, Pa...

Frequently Asked Questions

What is the definition of the NGS Oncology market?

How will the NGS Oncology market drivers and restraints affect the market dynamics? What forces will shape the NGS Oncology industry going forward?

The market major growth driver - Increasing Cancer Prevalence Fueling The Growth Of The Market Due To Rising Demand For Precision Diagnostics. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the NGS Oncology market?

The ngs oncology market size has grown rapidly in recent years. It will grow from $17.36 billion in 2024 to $19.33 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising cancer incidence, growing research in cancer genomics, increasing public awareness, expansion of healthcare infrastructure, and rising demand for personalized medicine. The ngs oncology market size is expected to see rapid growth in the next few years. It will grow to " $29.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the growth of companion diagnostics, the rising prevalence of cancer, the increase in government and healthcare investments, the expansion of clinical applications, and the rising popularity of targeted therapies. Major trends in the forecast period include the integration of AI and machine learning, advancements in single-cell sequencing, enhanced sequencing platforms, advancements in liquid biopsy technology, and advancements in high-throughput sequencing platforms. For further insights on this market, request a sample here

How is the NGS Oncology market segmented?

The ngs oncologymarket covered in this report is segmented –
1) By Sequencing Technology: Targeted Sequencing; Genomics; Transcriptomics; Epigenomics
2) By Offering: Platform; Kits; Services
3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
4) By Application: Genetic Screening; Hereditary Genetic Testing; Hematological Malignancies; Solid Tumors; Other Applications
5) By End User: Hospitals And Clinics; Clinical Research Organizations (CROs); Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users Subsegments:
1) By Targeted Sequencing: Whole Exome Sequencing (WES); Amplicon-Based Sequencing; Hybridization-Based Sequencing
2) By Genomics: Whole Genome Sequencing (WGS); Structural Variant Detection; Copy Number Variation (CNV) Analysis
3) By Transcriptomics: RNA Sequencing; Single-Cell Transcriptomics; Non-coding RNA Analysis
4) By Epigenomics: DNA Methylation Sequencing; Chromatin Immunoprecipitation Sequencing; Histone Modification Analysis For further insights on this market, request a sample here

Which region has the largest share of the NGS Oncology market? What are the other regions covered in the report?

North America was the largest region in the NGS oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the NGS oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the NGS Oncology market?

What are the key trends in the NGS Oncology market?

Major trends in this market include Next-Generation Sequencing Technologies Transforming Oncology Research. For further insights on this market, request a sample here.